Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development as a COVID-19 therapeutic.

Biotechnology

Health Care

Therapeutics

ExeVir

ExeVir's headquarters in Zwijnaarde, Belgium

Torsten Mummenbrauer

Viki Bockstal

Caroline Sagaert

Fiona Du Monceau

Erica Whittaker

Michel Kazatchkine

Caroline Thielen

Katja Rosenkranz

Jérôme Van Biervliet

Joël Henneghien

The Advisory Board Team at ExeVir comprises industry experts who provide strategic guidance and insights to streamline the development and commercialization of innovative antibody-based therapies. By leveraging their extensive experience in viral infectious diseases and biopharmaceuticals, the team helps shape the company's research direction and enhances stakeholder engagement, ensuring that ExeVir remains at the forefront of rapid viral control solutions.

Advisory Board Team

The Leadership Team at ExeVir is responsible for shaping the strategic direction and vision of the company, guiding the development of innovative therapies targeting viral infections. With a mix of executive leadership and scientific expertise, the team collaborates to drive research initiatives, oversee clinical trials, and ensure the effective deployment of resources to accelerate the advancement of their pipeline, particularly in the context of COVID-19 therapeutics.

Leadership Team

The Finance and Operations Team at ExeVir is responsible for ensuring the financial health and operational efficiency of the company. This team manages budgeting, financial forecasting, and resource allocation to support the rapid development of innovative antiviral therapies. They also streamline operational processes, ensuring that the company can effectively respond to the urgent needs of patients facing viral infections.

Finance and Operations Team

The Research and Development Team at ExeVir is responsible for pioneering the discovery and optimization of single-domain antibody therapies aimed at combating viral infections. They conduct cutting-edge research, oversee preclinical development, and collaborate closely to advance the company's lead drug candidate in the fight against COVID-19, ensuring that innovative solutions are effectively transitioned from the lab to clinical application.

ExeVir

Org chart

Board & advisors

Teams

Advisory Board Team

Leadership Team

Finance and Operations Team

Research and Development Team

Offices

ExeVir

Org chart

Board & advisors

Teams

Advisory Board Team

Leadership Team

Finance and Operations Team

Research and Development Team

Offices

Related companies